At this week's Benzinga Cannabis Conference in Chicago, the general mood among industry leaders was cautiously optimistic, despite ongoing challenges. While capital shortages and regulatory hurdles continue to frustrate many cannabis businesses, there was a sense of hope for the future, driven by legislative developments and emerging market trends. Here are the key takeaways:
OG Article: here
View our Fair Use Policy: here
Watch the Live Show HERE
Watch the Commentary Here
1. Lack of Capital
The scarcity of investment capital remains a critical concern. Business insiders consistently expressed the difficulty of accessing funds, with many lamenting that the industry is ripe with opportunities that can't be capitalized on due to funding issues. Although debt options are available, a growing number of companies are becoming wary of taking on additional debt due to mounting financial pressures.
Beau Whitney of Whitney Economics presented forecasts for the U.S. cannabis industry, estimating it could reach $48 billion in 2030 and $78 billion by 2035. Interestingly, while California remains the top state for investment potential through 2030, Texas is projected to take the lead by 2035. However, many attendees appeared skeptical about California, with several choosing to shift their focus to other markets due to the state's persistent challenges.
2. Legislative Optimism
Despite the challenges, there was a sense of optimism surrounding legislative changes that could positively impact the cannabis industry. Discussions revolved around:
The SAFER Banking Act, which could improve access to financial services for cannabis businesses.
A commerce clause lawsuit that could redefine interstate cannabis commerce.
The possibility of rescheduling cannabis to Schedule III under federal law, which could ease some regulatory burdens.
Attendees felt that these efforts are closer to fruition than before, with each holding the potential to create significant shifts in the industry.
3. Conflict Between Hemp and Regulated Cannabis
A heated topic at the conference was the ongoing conflict between intoxicating hemp products and regulated cannabis. Many in the industry feel that the proliferation of hemp-derived products like Delta-8 THC is undermining the regulated cannabis market. One panel, which was packed with attendees, highlighted the tension between advocates of strict regulation and those favoring more flexibility for hemp-derived products.
The battle in Florida between legalizing adult-use cannabis and the unrestricted sale of hemp products was particularly emphasized. With $100 million already spent on this state amendment battle, some attendees felt that these resources could have been better used to support advocacy programs or bolster the regulated industry.
4. Hemp Beverages
Interestingly, hemp beverage companies made a strong showing at the conference, with several booths offering THC-infused drinks to curious attendees. Unlike cannabis companies, which were unable to provide product samples due to regulations, hemp beverage makers freely handed out their products, which seemed to attract considerable interest. This trend highlights the increasing popularity of hemp drinks, even as the broader debate over hemp regulation rages on.
Overall, the Benzinga Cannabis Conference captured the industry's mixed sentiment: while the market remains difficult, particularly with capital constraints and regulatory issues, there is cautious optimism that upcoming legislative shifts could open new doors for growth and innovation.
Comments